• via BBC News
220 Children Enter Puberty Blocker Trial After Safety Ban
King's College study tests banned drugs on under-16s amid ethical backlash and Cass review warnings
A new UK trial revives puberty blockers for gender-distressed youth despite a national ban on safety grounds, exposing persistent gaps in evidence-based child health policy. This move highlights cross-party failures to prioritize prevention over reactive research, deepening NHS trust erosion.